InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,048.42
(
0.00%
)
US TECH 100
17,136.00
(
0.93%
)
Dow Jones
38,085.80
(
0.00%
)
Brent Oil
88.50
(
0.39%
)
Bitcoin
64,393.14
(
-0.14%
)
Post# of 251606
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ciotera

Send PM Follow Ignore
Followers 8
Posts 511
Boards Moderated 0
Alias Born 08/03/2005

ciotera

Re: DewDiligence post# 211448

Tuesday, 05/23/2017 5:21:50 PM

Tuesday, May 23, 2017 5:21:50 PM

Post# of 251606
Re: Keytruda

Agree that this isn't super consequential commercially.
CRC approval is for effectively 3rd line after both FOLFOX and FOLFIRI and MSI-High within that already small population is not very common (15%?)
But it is important as the first approval that's not tissue-specific. Sets a precedent. I think more will follow.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up